Publications by authors named "Linus D Kloker"

Claim this Profile
T
Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing.
Maxim F Carle, Tahereh Mohammadian Gol, Justin S Antony, Alicia Roig-Merino, Mary E Carter, Linus D Kloker

Mol Ther Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT).
Tim Flaadt, Lauriane Lemelle, Michael Abele, Calogero Virgone, Tal Ben-Ami, Linus D Kloker

Lung Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Pulmonary Ewing sarcoma disguised as non-small cell lung cancer.
Mary E Carter, Alessia Benegiamo-Chilla, Linus D Kloker, Nikolas Paulsen, Vlatko Potkrajcic

Front Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Linus D Kloker, Mirjana Sidiras, Tim Flaadt, Ines B Brecht, Christoph K W Deinzer

Lung Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma.
Can Yurttas, Julia Beil, Susanne Berchtold, Irina Smirnow, Linus D Kloker

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model.
Jana Koch, Julia Beil, Susanne Berchtold, Dina Mönch, Annika Maaß, Linus D Kloker

Viruses· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma.
Linus D Kloker, Branko Calukovic, Katrin Benzler, Alexander Golf, Sebastian Böhm

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms.
Linus D Kloker, Susanne Berchtold, Irina Smirnow, Julia Beil, Andreas Krieg

BMC Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oncolytic Herpes Simplex Virus Talimogene Laherparepvec Shows Promising Efficacy in Neuroendocrine Cancer Cell Lines.
Linus D Kloker, Susanne Berchtold, Irina Smirnow, Martin Schaller, Birgit Fehrenbacher

Neuroendocrinology· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional tumor cell cultures employed in virotherapy research.
Linus D Kloker, Can Yurttas, Ulrich M Lauer

Oncolytic Virother· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis